Hull Hans (CIK 1614876) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-01-27). Recent activity: Buy PLRX (40,150 shares), Sell PLRX (15,936 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-27 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Business Officer | Buy | 40,150 | $0 |
| 2025-01-22 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Business Officer | Sell | 15,936 | $178,483 |
Source: SEC Form 4 filings · as of 2025-01-27